Division of Diabetes Endocrinology and Metabolism Archive — Page 1 of 6
-
February 24, 2025
Leadership announced for Division of Diabetes, Endocrinology and Metabolism
An interim plan has been announced to fill the roles held by Alvin C. Powers, MD, in Vanderbilt’s Division of Diabetes, Endocrinology and Metabolism. -
October 16, 2024
Danielle Dean receives award for excellence in the field of islet research
Dean identified a liver-alpha cell axis (LACA), a crosstalk between liver glucagon signaling and alpha cell sensing of amino acids. -
July 3, 2024
Couple’s legacy of giving results in transformative change in endocrinology at Vanderbilt
“As I worked at Vanderbilt, I became so attached to the division, and when I had the ability to do it, I wanted to give back.” -
March 28, 2024
Teams to create one-stop resource for human pancreatic data to foster diabetes research
Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research. -
February 2, 2024
Study links small pancreas size to faster progression to stage 3 Type 1 diabetes
The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials. -
January 4, 2024
Study shows liraglutide results in increased insulin sensitivity independent of weight loss
-
December 4, 2023
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.